Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11034933
Methods for selectively expanding and enriching cells transduced with chimeric antigen receptors and treating HIV infection
granted -
US 11034750
Chimeric antigen receptor (CAR) comprising a CD19-binding domain
granted -
US 11034739
Ligand-guided phagocytosis based therapy for treatment of Alzheimer's disease and other neurodegenerative diseases
granted -
US 11033530
Devices and methods for facilitating and controlling use of a medication
granted -
US 11034958
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
granted -
US 11034694
Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists
granted -
US 11033635
Antibody-STING agonist conjugates and their use in immunotherapy
granted -
US 11033569
Compounds,Compositions, and methods for the treatment of disease
granted -
US 11033611
Compositions and methods for administration of an enzyme to a subject's airway
granted -
US 11033587
Administration of cells and cellular extracts for rejuvenation
granted -
US 11033539
Compounds of formulas (VII), (VIII), (IX), (XI), (XII), (XIII), and (XIV) as muscarinic receptor 4(M4) antagonists for treating neurological diseases
granted -
US 11033612
Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria
granted -
US 11034736
Anti-viral cnidarins
granted -
US 11034705
Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
granted -
US 11034700
Substituted pyrrolidine compound and use thereof
granted -
US 11034684
Isoxazole analogs as FXR agonists and methods of use thereof
granted -
US 11034956
Oligonucleotide comprising an inosine for treating DMD
granted -
US 11034662
Substituted phenothiazines as mitochondrial agents
granted -
US 11034672
Tyrosine kinase inhibitor compositions, methods of making and methods of use
granted -
US 11034667
Selective histone deacetylase inhibitors for the treatment of human disease
granted -
US 11033659
Nanofiber structures and methods of synthesis and use thereof
granted -
US 11033640
Enteric CT contrast material based on low-z atoms
granted -
US 11034660
Hydrazide containing nuclear transport modulators and uses thereof
granted -
US 11033623
Magnetic stem cell therapy for lesions
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.